To view this email as a web page, click here.
 
DRUG APPROVALS
 
New abuse-deterrent opioid available
A new abuse-deterrent painkiller—oxycodone hydrochloride (RoxyBond, Inspirion Delivery Services)—will be available soon after receiving FDA approval.
Read more
 
FDA approves targeted leukemia drug for certain patients, plus 2 more
Late last week, FDA approved a new drug to treat acute myeloid leukemia as well as the first treatment for Batten disease. FDA also expanded the use of a current drug to treat liver cancer.
Read more
 
FDA clears second Remicade biosimilar
In what is expected to produce hefty savings for rheumatoid arthritis (RA) patients and the healthcare system, FDA approved the second biosimilar to Remicade.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.